Skip to main content
Caplight Logo









General Control

General Control

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://generalcontrol.inc/

Last Round

Seed

Nov 18, 2025

Total Funding Raised

$5.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

General Control is a biotechnology company that develops programmable epigenetic therapies to address age-related diseases by precisely regulating gene expression.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

epigenetic editinggene expression modulationsynthetic transcription factorsepigenetic therapyepigenetic medicinegene regulationbiotech platformtherapeutic platformage-related diseasemultifactorial diseaseepigenetic reprogramminggene therapydrug discoveryprecision medicinelongevity biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

General Control Comparables

Compare General Control with similar companies based on industry and business-model similarity.

General Control comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Moonwalk Biosciences
86%
Epitome Therapeutics
85%
Tune Therapeutics
83%

General Control Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 18, 2025

Key People

Founding team and executive leadership

Lada Nuzhna

Founder, CEO

Founding Team

General Control Investors

Notable investors and investment history

General Control investors
InvestorRounds
age1Seed
Fifty YearsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 32% MoM.

  • Nov 18, 2025

    $5.5M round led by age1 and Fifty Years.

General Control Filings

Explore SEC and related filing metadata, where available.

General Control filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about General Control's valuation, stock price, and market status.

Is General Control a public or private company?

General Control is a private company.

What is the current stock price of General Control?

General Control is a private company with no public stock price. Caplight tracks General Control's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is General Control worth (valuation)?

Valuation information for General Control is not publicly available.

Can I buy General Control stock?

General Control shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was General Control's last funding round?

General Control's most recent funding round was Seed on November 18, 2025.

Who are the main investors in General Control?

Key investors in General Control include age1, Fifty Years.

Will General Control IPO soon?

No public IPO plans have been announced for General Control.

How can I track General Control secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor General Control's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range5
Year Founded2024
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?